Clinical trials
Musculoskeletal Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 8 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Recruiting | 10 |
| Active, not recruiting | 9 |
| Terminated | 8 |
| Unknown status | 7 |
| Enrolling by invitation | 4 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| QED Therapeutics, a BridgeBio company | 8 |
| AbbVie | 7 |
| Laval University | 4 |
| McGill University | 4 |
| BioMarin Pharmaceutical | 3 |
| Fulcrum Therapeutics | 3 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 3 |
| PTC Therapeutics | 3 |
| Amgen | 2 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Musculoskeletal Diseases | 74 |
| Genetic Diseases, Inborn | 19 |
| Bone Diseases | 14 |
| Joint Diseases | 14 |
| Neuromuscular Diseases | 14 |
| Muscular Dystrophies | 13 |
| Arthritis | 12 |
| Muscular Diseases | 12 |
| Osteochondrodysplasias | 10 |
| Dwarfism | 9 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.